Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-607-2 | CAS number: 65-31-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:
The acute oral toxicity dose (LD50) was considered based on different studies conducted on rats and mice for the test chemical. The LD50 value is 65 mg/kg bw. The study concluded that the LD50 value is between 50-300 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified in “Category 3” for acute oral toxicity.
Acute Inhalation Toxicity:
The acute inhalation toxicity study need not be conducted because exposure to humans via inhalation route is not likely taking into account due to very low vapour pressure of the test chemical, which is reported to be 1.235E-19 Pa (9.26E-22 mm Hg) at 25 °C and particle size of the test chemical which is determined to be in the range of 147 micron to 52 micron and which is much larger size range compared to the inhalable particulate matter. Thus, exposure to inhalable dust, mist and vapour of the chemical is highly unlikely. Therefore this study is considered for waiver.
Acute Dermal toxicity:
The acute dermal toxicity dose (LD50) was considered based on different studies conducted on rats and rabbits for the test chemical. The LD50 value is >5000 mg/kg bw. The study concluded that LD50 value is >2000 mg/kg bw, for acute dermal toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data is from Authoritative database
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- Acute oral toxicity study of test chemical was performed in rats.
- GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- not specified
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Details on oral exposure:
- not specified
- Doses:
- 65 mg/kg bw
- No. of animals per sex per dose:
- not specified
- Control animals:
- not specified
- Details on study design:
- not specified
- Statistics:
- not specified
- Preliminary study:
- not specified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 65 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 50% mortality was observed
- Mortality:
- 50% mortality was observed at 65 mg/kg bw.
- Clinical signs:
- other: not specified
- Gross pathology:
- not specified
- Other findings:
- not specified
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- The lethal concentration (LD50) value for acute oral toxicity test was considered to be 65 mg/kg bw, when rats were treated with the given test chemical orally.
- Executive summary:
Acute oral toxicity study was performed in rats using the given test chemical at the dose concentration of 65 mg/kg bw.
Animals were observed for mortality. 50% mortality was observed at dose 65 mg/kg bw.
Hence, the LD50 value was considered to be 65 mg/kg bw, when rats were treated with the given test chemical orally.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 65 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from authoritative database
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Quality of whole database:
- Waiver
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Remarks:
- experimental data from various test chemicals
- Justification for type of information:
- Data is summarized based on the available information from various test chemicals.
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- WoE report is based on 2 acute dermal toxicity studies as- WoE 2 and WoE 3.
Acute dermal toxicity test was carried out to study the effects of the test chemicals on rodents. - GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Species:
- other: 2. rat 3. rabbit
- Strain:
- other: 2. not specified 3. White Russian
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 2. not specified
3. TEST ANIMALS
- Source: Asta Pharma AG.
- Weight at study initiation: weight males 2.38-2.95 kg, females 2.48-2.93 kg.
- Fasting period before study: feed was withheld 16 h prior to dosing.
- Diet (e.g. ad libitum): feed was given - Type of coverage:
- other: 2. Dermal 3. occlusive
- Vehicle:
- other: 2. not specified 3. water
- Details on dermal exposure:
- 2. not specified
3. not specified - Duration of exposure:
- 2. not specified
3. 24 h - Doses:
- 2. 5000 mg/kg
3. 2000 mg/kg - No. of animals per sex per dose:
- 2. not specified
3. 5/sex/treatment - Control animals:
- not specified
- Details on study design:
- 2. not specified
3. - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Mortality and clinical signs was observed from 0-6 hrs, and daily thereafter for 14 days. Body weight on day 0, 7 and 14.
- Necropsy of survivors performed: yes, on day 14. - Statistics:
- 2. not specified
3. not specified - Preliminary study:
- 2. not specified
3. not specified - Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 2. No mortality was observed at 5000 mg/kg bw in treated animals.
3. No mortality was observed at 2000 mg/kg bw in treated animals. - Clinical signs:
- other: 2. not specified 3. A slight reddening was observed immediately after removal of the patches in all animals. In some animals the reddening was present till the end of the observation period.
- Gross pathology:
- 2. not specified
3. No treatment-related effects were observed in necropsy. - Other findings:
- 2. not specified
3. not specified - Interpretation of results:
- other: Not classified
- Conclusions:
- According to CLP regulation, the given test chemical cannot be classified for acute dermal toxicity, as the LD50 value is >5000 mg/kg bw.
- Executive summary:
In different studies, the given test chemical has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats and rabbits for test chemical. The studies are summarized as below -
The reported study was mentioned in authoritative database and conducted to determine acute dermal toxicity profile of the given test chemical. The study was performed in rats at the concentration of 5000 mg/kg bw. Animals were observed for mortality. No mortality was observed at 5000 mg/kg bw in treated animals. Therefore, the LD50 value was considered to be >5000 mg/kg bw, when rats were treated with the given test chemical by dermal application.
The above study is supported with another study available in authoritative database and secondary report and conducted in male and female rabbits at the concentration of 2000 mg/kg bw.
The given test chemical (purity 99.8%) was dissolved in water and applied to the skin of rabbits by occlusive patch for 24 hours. Mortality and clinical signs was observed from 0-6 hours and daily thereafter for 14 days. Body weight was observed on day 0, 7 and 14. Necropsy of survivors performed on day 14.
No mortality was observed at 2000 mg/kg bw in treated animals. A slight reddening was observed immediately after removal of the patches in all animals. In some animals the reddening was present till the end of the observation period. No treatment-related effects were observed in body weight. No treatment-related effects were observed in necropsy.
Hence, the LD50 value was considered to be >2000 mg/kg bw, when male and female White Russian rabbits were treated with the given test chemical by dermal application occlusively.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from authoritative database.
Additional information
Acute oral toxicity:
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents,
i.e. most commonly in rats and mice for test chemical. The studies are summarized as below-
The reported study was mentioned in different authoritative databases and handbooks and designed to determine the acute oral toxicity profile of the given test chemical in rats at the dose concentration of 65 mg/kg bw. Animals were observed for mortality. 50% mortality was observed at dose 65 mg/kg bw. Hence, the LD50 value was considered to be 65 mg/kg bw, when rats were treated with the given test chemical orally.
The above study is supported with another study mentioned in different authoritative databases and handbook for the given test chemical. The acute oral toxicity study was performed in mouse at the dose concentration of 65 mg/kg bw. Animals were observed for mortality. 50% mortality was observed at dose 65 mg/kg bw. Hence, the LD50 value was considered to be 65 mg/kg bw, when mouse were treated with the given test chemical orally.
Both the above studies are further supported with the study mentioned in authoritative database for the given test chemical. The acute oral toxicity study was performed in rats at the dose concentration of 150 mg/kg bw. Animals were observed for mortality and clinical signs. 50% mortality was observed at dose 150 mg/kg bw. In clinical signs observations, increased urine volume, behavioural rigidity and tremor were seen. Hence, the LD50 value was considered to be 150 mg/kg bw, when rats were treated with test chemical orally.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is between 50-300 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified in “Category 3” for acute oral toxicity.
Acute Inhalation Toxicity:
The acute inhalation toxicity study need not be conducted because exposure to humans via inhalation route is not likely taking into account due to very low vapour pressure of the test chemical, which is reported to be 1.235E-19 Pa (9.26E-22 mm Hg) at 25 °C and particle size of the test chemical which is determined to be in the range of 147 micron to 52 micron and which is much larger size range compared to the inhalable particulate matter. Thus, exposure to inhalable dust, mist and vapour of the chemical is highly unlikely. Therefore this study is considered for waiver.
Acute Dermal Toxicity:
In different studies, the given test chemical has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats and rabbits for test chemical. The studies are summarized as below -
The reported study was mentioned in authoritative database and conducted to determine acute dermal toxicity profile of the given test chemical. The study was performed in rats at the concentration of 5000 mg/kg bw. Animals were observed for mortality. No mortality was observed at 5000 mg/kg bw in treated animals. Therefore, the LD50 value was considered to be >5000 mg/kg bw, when rats were treated with the given test chemical by dermal application.
The above study is supported with another study available in authoritative database and secondary report and conducted in male and female rabbits at the concentration of 2000 mg/kg bw.
The given test chemical (purity 99.8%) was dissolved in water and applied to the skin of rabbits by occlusive patch for 24 hours. Mortality and clinical signs was observed from 0-6 hours and daily thereafter for 14 days. Body weight was observed on day 0, 7 and 14. Necropsy of survivors performed on day 14.
No mortality was observed at 2000 mg/kg bw in treated animals. A slight reddening was observed immediately after removal of the patches in all animals. In some animals the reddening was present till the end of the observation period. No treatment-related effects were observed in body weight. No treatment-related effects were observed in necropsy.
Hence, the LD50 value was considered to be >2000 mg/kg bw, when male and female White Russian rabbits were treated with the given test chemical by dermal application occlusively.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical cannot be classified for acute dermal toxicity.
Justification for classification or non-classification
Based on the above studies on test chemical, it can be concluded that LD50 value is between 50-300 mg/kg bw, for acute oral toxicity and LD50 value is >2000 mg/kg bw, for acute dermal toxicity. Thus, comparing this range and value with the criteria of CLP regulation, the given test chemical can be classified in “Category 3” for acute oral toxicity and cannot be classified for acute dermal toxicity. For acute inhalation toxicity wavier was added so, not possible to classify.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.